BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 11792152)

  • 1. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.
    Wudel LJ; Wright JK; Debelak JP; Allos TM; Shyr Y; Chapman WC
    J Surg Res; 2002 Jan; 102(1):50-6. PubMed ID: 11792152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss.
    Worobetz LJ; Inglis FG; Shaffer EA
    Am J Gastroenterol; 1993 Oct; 88(10):1705-10. PubMed ID: 8213711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gallstones in patients with morbid obesity. Relationship to body weight, weight loss and gallbladder bile cholesterol solubility.
    Shiffman ML; Sugerman HJ; Kellum JH; Brewer WH; Moore EW
    Int J Obes Relat Metab Disord; 1993 Mar; 17(3):153-8. PubMed ID: 8385075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.
    Haal S; Guman MSS; Boerlage TCC; Acherman YIZ; de Brauw LM; Bruin S; de Castro SMM; van Hooft JE; van de Laar AWJM; Moes DE; Schouten M; Schouten R; van Soest EJ; van Veen RN; de Vries CEE; Fockens P; Dijkgraaf MGW; Gerdes VEA; Voermans RP
    Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):993-1001. PubMed ID: 34715031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gallbladder management in obesity surgery.
    Mason EE; Renquist KE
    Obes Surg; 2002 Apr; 12(2):222-9. PubMed ID: 11975217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss.
    Sugerman HJ; Brewer WH; Shiffman ML; Brolin RE; Fobi MA; Linner JH; MacDonald KG; MacGregor AM; Martin LF; Oram-Smith JC
    Am J Surg; 1995 Jan; 169(1):91-6; discussion 96-7. PubMed ID: 7818005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative ultrasound and prophylactic ursodiol for gallstone prevention following laparoscopic gastric bypass.
    Scott DJ; Villegas L; Sims TL; Hamilton EC; Provost DA; Jones DB
    Surg Endosc; 2003 Nov; 17(11):1796-802. PubMed ID: 12958683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity.
    Shiffman ML; Sugerman HJ; Kellum JM; Brewer WH; Moore EW
    Am J Gastroenterol; 1991 Aug; 86(8):1000-5. PubMed ID: 1858735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of rapid weight reduction on risk of cholelithiasis after bariatric surgery.
    Iglézias Brandão de Oliveira C; Adami Chaim E; da Silva BB
    Obes Surg; 2003 Aug; 13(4):625-8. PubMed ID: 12935366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial).
    Haal S; Guman MSS; de Brauw LM; van Veen RN; Schouten R; Fockens P; Gerdes VEA; Dijkgraaf MGW; Voermans RP
    Trials; 2020 Jul; 21(1):676. PubMed ID: 32703246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).
    Boerlage TCC; Haal S; Maurits de Brauw L; Acherman YIZ; Bruin S; van de Laar AWJM; Moes DE; van Wagensveld BA; de Vries CEE; van Veen R; Schouten R; Dijkgraaf MG; Fockens P; Gerdes VEA; Voermans RP
    BMC Gastroenterol; 2017 Dec; 17(1):164. PubMed ID: 29262795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial.
    Miller K; Hell E; Lang B; Lengauer E
    Ann Surg; 2003 Nov; 238(5):697-702. PubMed ID: 14578732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of gallbladder emptying in gallstone formation during diet-induced rapid weight loss.
    Gebhard RL; Prigge WF; Ansel HJ; Schlasner L; Ketover SR; Sande D; Holtmeier K; Peterson FJ
    Hepatology; 1996 Sep; 24(3):544-8. PubMed ID: 8781321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in gallbladder motility and gallstone formation following laparoscopic gastric banding for morbid obestity.
    Al-Jiffry BO; Shaffer EA; Saccone GT; Downey P; Kow L; Toouli J
    Can J Gastroenterol; 2003 Mar; 17(3):169-74. PubMed ID: 12677265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy.
    Li VK; Pulido N; Fajnwaks P; Szomstein S; Rosenthal R; Martinez-Duartez P
    Surg Endosc; 2009 Jul; 23(7):1640-4. PubMed ID: 19057954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary?
    Caruana JA; McCabe MN; Smith AD; Camara DS; Mercer MA; Gillespie JA
    Surg Obes Relat Dis; 2005; 1(6):564-7; discussion 567-8. PubMed ID: 16925292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight.
    Broomfield PH; Chopra R; Sheinbaum RC; Bonorris GG; Silverman A; Schoenfield LJ; Marks JW
    N Engl J Med; 1988 Dec; 319(24):1567-72. PubMed ID: 3200265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein-E genotype and the risk of developing cholelithiasis following bariatric surgery: a clue to prevention of routine prophylactic cholecystectomy.
    Abu Abeid S; Szold A; Gavert N; Goldiner I; Grynberg E; Peretz H; Konikoff FM
    Obes Surg; 2002 Jun; 12(3):354-7. PubMed ID: 12087994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients?
    Swartz DE; Felix EL
    Surg Obes Relat Dis; 2005; 1(6):555-60. PubMed ID: 16925290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of cholelithiasis after sleeve gastrectomy and its association with weight loss: A two-centre retrospective cohort study.
    Manatsathit W; Leelasinjaroen P; Al-Hamid H; Szpunar S; Hawasli A
    Int J Surg; 2016 Jun; 30():13-8. PubMed ID: 27063855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.